Mebus MIM-Technik acquired by Acrotec Medtech
Mebus MIM-Technik, based in Neuhausen, Germany, has been acquired by the Acrotec Group’s Medtech division, headquartered in Develier, Switzerland. Founded almost twenty years ago by Michael Mebus, Mebus MIM-Technik has a particular focus and expertise in the design and production of small, complex metal and ceramic injection moulded parts with very tight tolerances.
Certified according to DIN EN ISO 13485:2016, the company serves as a strategic supplier to leading medical technology companies. Its products include small, single-use high-end surgical products such as forceps for laparoscopic and endoscopic instruments, components for waterjet surgery, or screws for orthodontic treatment. In addition, customers include companies in the mechanical engineering, aerospace and other microtechnology industries.
TRUSTED BY INDUSTRY’S BIGGEST NAMES
Discover how we help leading brands shape the industry conversation
| Contact us |
“The acquisition of Mebus is a perfect fit for us to expand Acrotec Medtech’s skills with real experts in their field,” stated Sébastien Virtel, CEO of the Medtech division of the Acrotec Group. “The level of mastery of this company’s MIM and CIM injection technologies allows us to accelerate our development in robotic surgery and endoscopy with complex single-use components, in perfect complementarity with our companies active in precision machining. Together with Friedrich Daniels, we are also strengthening our presence in Germany and our expertise in the medical device sector with this acquisition.“
“Joining the Acrotec Group is great news for the company I have been building and growing for almost 20 years,” added Michael Mebus, CEO of Mebus. “At a time when the question of my succession is being raised, it is a great opportunity to join a group that, thanks to its wide range of products and skills, remarkably complements Mebus as a holistic strategic partner for its development. I would like to thank my team, our customers and our partners for all the progress they have made, with the deep conviction that this new step will give us additional resources and offer us exceptional synergies to conquer new markets.”
